Valeant Pharmaceuticals and William Ackman, an activist investor, upped the ante in their joint bid for Allergan, the maker of Botox. Valeant increased the cash portion of the $53 billion offer and pledged to take it directly to shareholders if Allergan's board continued to oppose it. Ackman said he would try to oust six Allergan board members at a shareholders' meeting.